Results for:(20 found)
Apr 23, 2013 1:46PM on Top StocksBy Forbes Digital

The two companies were working together on DNA sequencing technology, but the pharmaceutical giant pulled out Tuesday.

Apr 11, 2013 9:23AM on Top StocksBy Benzinga

Amgen, Celgene and Pharmacyclics see short interest drop recently.

Mar 28, 2013 10:50AM on Top StocksBy Benzinga

There's mixed interest in biotech, biopharmaceutical and emerging pharma companies.

Mar 1, 2013 12:46PM on Top StocksBy MSN Money Partner

SunPower is initiated with an 'outperform,' and Deutsche Bank is downgraded to 'sell.'

Mar 1, 2013 10:22AM on Top StocksBy Stock Traders Daily

Earnings issues linger in every sector and guidance disappoints.

Jan 4, 2013 12:36PM on Top StocksBy MSN Money Partner

Under Armour is upgraded to 'outperform,' and First Solar is downgraded to 'underperform.'

Dec 28, 2012 12:36PM on Top StocksBy TheStockAdvisors

Speculators can buy a biotech stock while the more conservative should consider a biotech fund.

Nov 26, 2012 12:02PM on Top StocksBy MSN Money Partner

Aeropostale is downgraded to 'neutral,' and Yahoo is upgraded to 'conviction buy' at Goldman.

VIDEO ON MSN MONEY

DATA PROVIDERS

Copyright © 2013 Microsoft. All rights reserved.

Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.

Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.

Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.

TOP STOCKS

Will Monday's rally carry over?

The Dow jumps 109 points after rising as many as 191. Oil-price jitters and rising rates trim gains. Those factors and the Fed may weigh on markets Tuesday.

More

MARKET DISPATCHES

No more Dispatches; here's where to find market news

The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.

More

SMART SPENDING

Report: Hazards higher for poor kids

Children from lower income families are at greater risk of suffering accidental injuries and being sickened by food, according to a Consumer Federation of America study.

More

SMART TAXES

More